Nurix Therapeutics, Inc.
- Stock
- Ticker NRIX
- Nasdaq
Performance, volatility and drawdowns of Nurix Therapeutics, Inc. since 07/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $3,842. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −91.5% in 10/2023, measured from the peak in 01/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 11/2024 | 02/2025 | 05/2025 | 08/2025 | 11/2025 | 02/2026 | 05/2026 | 08/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 13 | 18 | 44 | 7.9 | 14 | 6.3 | 9.0 | 673 |
| Operating income | -65 | -63 | -48 | -91 | -83 | -92 | -94 | 559 |
| EBITDA | -62 | -61 | -46 | -89 | -81 | -90 | -92 | 562 |
| Net income | -59 | -56 | -43 | -86 | -78 | -87 | -90 | 550 |
| Earnings per share | -0.75 | -0.67 | -0.52 | -1.03 | -0.83 | -0.79 | -0.81 | 4.73 |
| Balance sheet | ||||||||
| Total assets | 669 | 615 | 592 | 522 | 688 | 636 | 536 | 1,195 |
| Liabilities | 142 | 134 | 144 | 150 | 149 | 155 | 133 | 227 |
| Equity | 527 | 481 | 448 | 372 | 539 | 481 | 403 | 968 |
| Cash | 110 | 76 | 84 | 78 | 247 | 71 | 68 | 720 |
| Cash flow | ||||||||
| Operating cash flow | -49 | -61 | -63 | -57 | -68 | -72 | -97 | 616 |
| Capital expenditure | -2.1 | -3.5 | -2.7 | -2.7 | -5.1 | -1.0 | -1.9 | -1.4 |
| Free cash flow | -51 | -65 | -66 | -60 | -73 | -73 | -99 | 614 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +82.6%, weakest 2022 at −62.1%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 13 Oct 2026 | $4.73 |
| 9 Jul 2026 | −$0.81 |
| 8 Apr 2026 | −$0.79 |
| 28 Jan 2026 | −$0.83 |
| 9 Oct 2025 | −$1.03 |
| 9 Jul 2025 | −$0.52 |
| 8 Apr 2025 | −$0.67 |
| 28 Jan 2025 | −$0.75 |
| 11 Oct 2024 | −$0.67 |
| 11 Jul 2024 | −$0.71 |
| 10 Apr 2024 | −$0.76 |
| 15 Feb 2024 | −$0.77 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.3bn
- Market cap in trading currency
- $1.40bn
- Enterprise value
- $684m
- P/E
- 5.6
- P/S
- 2.00
- P/B
- 1.45
- EV/Sales
- 0.97
- EV/EBITDA
- 2.3
- Earnings yield
- 17.9%
- FCF yield
- 26.3%
Results (last four quarters)
- Revenue
- $702m
- Gross profit
- –
- EBITDA
- $298m
- Net income
- $295m
- Earnings per share
- $2.30
- Revenue per share
- $6.43
- Revenue growth
- +8,426.3%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- 41.3%
- Net margin
- 42.0%
- Return on equity
- 44.0%
- Return on assets
- 24.7%
Balance sheet and cash flow
- Cash
- $720m
- Cash per share
- $6.59
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 8.44
- Book value per share
- $8.86
- Operating cash flow
- $379m
- Free cash flow
- $370m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 109m
- Volume
- 2.43m
- Avg. volume 3 months
- 2.41m
- Relative volume
- 1.0
Price and technicals
- Price
- $12.85
- 1 day
- −5.5%
- 52-week high
- $27.79
- 52-week low
- $12.85
- Distance to 52-week high
- −53.8%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −41.8%
- Distance to 200-day line
- −35.9%
- RSI (14)
- 21
- Volatility 1M
- 171.9%
Performance
- 1 week
- −17.0%
- 1 month
- −49.6%
- 3 months
- −51.1%
- 6 months
- −26.6%
- YTD
- −32.3%
- 1 year
- −10.3%
Dates
- Fiscal year end
- 30 Nov 2025
- Most recent quarter
- 31 Aug 2026
Frequently asked questions
How has NRIX performed since 07/2020?
$10,000 grew to $6,760 by 20 Nov 2026, which is −6.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is NRIX?
Volatility was 76.6% per year, measured on monthly returns. The largest decline from a peak was −91.5%, with the low in 10/2023.
How does NRIX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +12.0% per year at 15.1% volatility, NRIX returned −6.0% at 76.6%. The correlation of monthly returns was 0.44; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.